Methods of treating cancer include administering a therapeutically effective amount of a pharmaceutical composition containing a pharmaceutically acceptable carrier and a compound that is a GPR55 antagonist to a subject having a tumor including cancer cells that have developed a resistance to one or more chemotherapeutic agents. In embodiments, the compound is a fenoterol analogue, such as for example, MNF.
